Publications by authors named "Ina Mathilde Kjaer"

Claim this Profile
N
Natural Killer Cell Activity and Response to Neoadjuvant Treatment in Breast Cancer Patients.
Sofie Høier Gamborg-Kvist, Else Maae, Signe Timm, Ina Mathilde Kjær, Troels Bechmann

Int J Mol Sci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating methylated tumor DNA as a biomarker for mortality in recurrent breast cancer: An exploratory study.
Stine Bakkensen Bruun, Rikke Fredslund Andersen, Jonna Skov Madsen, Torben Frøstrup Hansen, Tomasz Piotr Tabor

Oncol Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA.
Ina Mathilde Kjær, Søren Kahns, Signe Timm, Rikke Fredslund Andersen, Jonna Skov Madsen

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting on circulating tumor DNA monitoring in metastatic cancer-From clinical validity to clinical utility.
Caroline Brenner Thomsen, Amanda Dandanell Juul, Anna Cecilie Lefèvre, Christina Glismand Truelsen, Edina Dizdarevic, Ina Mathilde Kjaer

Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning detects and visualizes bleeding events in electronic health records.
Jannik S Pedersen, Martin S Laursen, Thiusius Rajeeth Savarimuthu, Rasmus Søgaard Hansen, Anne Bryde Alnor

Res Pract Thromb Haemost· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer.
Ina Mathilde Kjær, Dorte Aalund Olsen, Ivan Brandslund, Troels Bechmann, Erik Hugger Jakobsen

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study.
Ina Mathilde Kjær, Dorte Aalund Olsen, Ivan Brandslund, Troels Bechmann, Erik Hugger Jakobsen

Sci Rep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR and EGFR ligands in serum in healthy women; reference intervals and age dependency.
Ina Mathilde Kjær, Dorte Aalund Olsen, Anne Alnor, Ivan Brandslund, Troels Bechmann

Clin Chem Lab Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a three-plex single molecule immunoassay enabling measurement of the EGFR ligands amphiregulin, betacellulin and transforming growth factor α simultaneously in human serum samples.
Dorte Aalund Olsen, Ina Mathilde Kjaer, Ivan Brandslund

J Immunol Methods· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive value of EGFR and EGFR-ligands in blood of breast cancer patients: a systematic review.
Ina Mathilde Kjaer, Troels Bechmann, Ivan Brandslund, Jonna Skov Madsen

Clin Chem Lab Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis